X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (536) 536
index medicus (317) 317
male (284) 284
female (277) 277
middle aged (155) 155
adult (153) 153
transient elastography (132) 132
hematology (123) 123
transient myeloproliferative disorder (113) 113
aged (105) 105
stroke (96) 96
risk factors (93) 93
down syndrome (91) 91
pediatrics (89) 89
gastroenterology & hepatology (85) 85
infant, newborn (77) 77
diagnosis (75) 75
oncology (75) 75
child (73) 73
fibrosis (69) 69
acute megakaryoblastic leukemia (65) 65
cirrhosis (65) 65
child, preschool (63) 63
clinical neurology (62) 62
down syndrome - complications (62) 62
infant (62) 62
liver (60) 60
transient ischemic attack (60) 60
biopsy (59) 59
leukemia (59) 59
liver cirrhosis (59) 59
children (58) 58
analysis (57) 57
health aspects (56) 56
retrospective studies (56) 56
animals (54) 54
disease (54) 54
thrombocytopenia (52) 52
medicine & public health (51) 51
treatment outcome (49) 49
peripheral vascular disease (48) 48
mutation (47) 47
acute myeloid-leukemia (46) 46
adolescent (46) 46
prognosis (46) 46
liver fibrosis (45) 45
care and treatment (44) 44
ischemic attack, transient - etiology (44) 44
down syndrome - genetics (43) 43
patients (43) 43
prospective studies (43) 43
platelet count (42) 42
surgery (42) 42
aspirin (40) 40
liver diseases (40) 40
platelet aggregation inhibitors - therapeutic use (40) 40
diagnosis, differential (38) 38
liver - pathology (38) 38
risk (38) 38
time factors (38) 38
down-syndrome (37) 37
medical research (37) 37
stroke - prevention & control (37) 37
research (36) 36
hepatitis (35) 35
liver cirrhosis - pathology (35) 35
gata1 transcription factor - genetics (34) 34
hepatitis c (34) 34
liver cirrhosis - diagnosis (34) 34
chronic hepatitis-c (33) 33
gata1 (33) 33
management (33) 33
medicine, general & internal (33) 33
infants (32) 32
medicine, experimental (32) 32
stroke - etiology (32) 32
abridged index medicus (31) 31
mortality (31) 31
therapy (31) 31
aspirin - therapeutic use (30) 30
follow-up studies (30) 30
thrombosis (30) 30
infection (29) 29
ischemic attack, transient - drug therapy (29) 29
recurrence (29) 29
hypertension (28) 28
infectious diseases (28) 28
pharmacology & pharmacy (27) 27
prevention (27) 27
severity of illness index (27) 27
aged, 80 and over (26) 26
clopidogrel (26) 26
elasticity imaging techniques - methods (26) 26
leukemia, megakaryoblastic, acute - genetics (26) 26
medicine (26) 26
natural-history (26) 26
neurosciences (26) 26
transient abnormal myelopoiesis (26) 26
acquired mutations (25) 25
biomarkers - blood (25) 25
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (684) 684
German (8) 8
French (3) 3
Russian (3) 3
Japanese (2) 2
Korean (1) 1
Polish (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 05/2012, Volume 10, Issue 5, pp. 799 - 806
Background:  Eltrombopag is an oral, non‐peptide thrombopoietin receptor agonist that has shown efficacy and safety in chronic immune thrombocytopenia (ITP).... 
pharmacokinetics | bleeding | eltrombopag | immune thrombocytopenia | Eltrombopag | Immune thrombocytopenia | Pharmacokinetics | Bleeding | MANAGEMENT | PLATELET COUNTS | ITP | HEALTHY-SUBJECTS | PURPURA | ADULTS | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | Benzoates - adverse effects | Japan - epidemiology | Blood Platelets - immunology | Hemorrhage - ethnology | Humans | Middle Aged | Hematologic Agents - pharmacokinetics | Male | Hemorrhage - prevention & control | Purpura, Thrombocytopenic, Idiopathic - blood | Purpura, Thrombocytopenic, Idiopathic - drug therapy | Time Factors | Purpura, Thrombocytopenic, Idiopathic - immunology | Placebos | Adult | Female | Blood Platelets - drug effects | Pyrazoles - pharmacokinetics | Hydrazines - administration & dosage | Pyrazoles - adverse effects | Hematologic Agents - adverse effects | Double-Blind Method | Administration, Oral | Hemorrhage - immunology | Hydrazines - pharmacokinetics | Treatment Outcome | Hemorrhage - blood | Purpura, Thrombocytopenic, Idiopathic - ethnology | Benzoates - administration & dosage | Receptors, Thrombopoietin - agonists | Asian Continental Ancestry Group | Pyrazoles - administration & dosage | Platelet Count | Blood Platelets - metabolism | Aged | Hematologic Agents - administration & dosage | Receptors, Thrombopoietin - blood | Chronic Disease | Benzoates - pharmacokinetics | Hydrazines - adverse effects | Thrombocytopenia | thrombopoietin receptors | Transient ischemic attack | Platelets | Thrombosis
Journal Article
The Indian Journal of Pediatrics, ISSN 0019-5456, 3/2014, Volume 81, Issue 3, pp. 266 - 269
Journal Article
European Journal of Haematology, ISSN 0902-4441, 11/2014, Volume 93, Issue 5, pp. 439 - 445
Objectives Thrombocytopenia is an independent adverse prognostic factor in patients with Myelodysplastic syndromes (MDS). Azacitidine, first‐line treatment for... 
thrombocytopenia | eltrombopag | Myelodysplastic syndrome | azacitidine | thrombopoietin‐receptor | Thrombocytopenia | Thrombopoietin-receptor | Eltrombopag | Azacitidine | LEUKEMIA GROUP-B | SURVIVAL | STEM-CELLS | IMPACT | thrombopoietin-receptor | PROLIFERATION | HEMATOLOGY | CANCER | Blood Platelets - pathology | Benzoates - adverse effects | Azacitidine - adverse effects | Humans | Middle Aged | Male | Antineoplastic Agents - administration & dosage | Thrombocytopenia - complications | Thrombocytopenia - drug therapy | Antineoplastic Agents - adverse effects | Ischemic Attack, Transient - etiology | Aged, 80 and over | Female | Blood Platelets - drug effects | Drug Therapy, Combination | Hydrazines - administration & dosage | Myelodysplastic Syndromes - drug therapy | Azacitidine - administration & dosage | Ischemic Attack, Transient - pathology | Pyrazoles - adverse effects | Hematopoietic Stem Cells - drug effects | Myelodysplastic Syndromes - metabolism | Treatment Outcome | Thrombocytopenia - pathology | Myelodysplastic Syndromes - complications | Receptors, Thrombopoietin - metabolism | Remission Induction | Thrombocytopenia - metabolism | Venous Thrombosis - etiology | Benzoates - administration & dosage | Drug Synergism | Receptors, Thrombopoietin - agonists | Pilot Projects | Pyrazoles - administration & dosage | Platelet Count | Aged | Venous Thrombosis - pathology | Cell Cycle - drug effects | Myelodysplastic Syndromes - pathology | Hydrazines - adverse effects | Antimitotic agents | Medical research | Complications and side effects | Care and treatment | Safety and security measures | Leukemia | Clinical trials | Medicine, Experimental | Antineoplastic agents | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Cancer and Oncology | Klinisk medicin | Cancer och onkologi
Journal Article
Emergency Medicine Clinics of North America, ISSN 0733-8627, 2009, Volume 27, Issue 3, pp. 505 - 523
Journal Article
Journal of Gastroenterology, ISSN 0944-1174, 8/2010, Volume 45, Issue 8, pp. 876 - 884
Journal Article
American Journal of Medical Genetics Part A, ISSN 1552-4825, 04/2017, Volume 173, Issue 4, pp. 897 - 904
Journal Article